Renewal Is Now a Data Exercise
One of the biggest mistakes I still see in the market is treating renewal as if it starts when the first meeting lands in the diary. It does not.
By the time many brokers formally begin renewal discussions, underwriters have already formed a view. They have been observing signals around risk, volatility and organisational control for months. The renewal meeting is no longer where the story begins; it is where the market decides whether the story is credible.
That shift matters because employers are operating in a very different environment. HR, Finance and Risk teams are dealing with more visible absence pressure, rising mental health claims and growing scrutiny of workforce resilience. The data reflects that reality. CIPD’s 2024 Health and Wellbeing Report found that sickness absence reached 9.4 days per employee, up from 7.8 days in 2023 and 5.8 days in 2022.
What this means in practice is that claims behaviour, attendance trends, stress-related absence and benefits utilisation have already become part of the underwriting narrative, whether organisations acknowledge it or not. A broker who waits until 30 or 60 days before renewal to gather evidence is not shaping that narrative. They are responding to it. In a hard market, that is a weak commercial position.
The organisations that approach renewal differently understand that the conversation starts much earlier. Ninety days creates enough runway to move beyond reporting and into genuine insight. It allows employers to demonstrate not only what happened last year, but also what they understand about current exposure, emerging risks and the actions they are taking to manage them.
There is also an important compliance dimension. The Health and Safety Executive (HSE) has made it clear that employers have a legal duty to assess and manage work-related stress, identifying demands, control, support, relationships, role and change as the core risk factors.
That legal obligation matters. The commercial implications matter even more.
HSE reported that 40.1 million working days were lost to work-related ill health and non-fatal injuries in 2024/25. Of those, 22.1 million days were attributable to stress, depression or anxiety. When brokers can demonstrate that these risks are being monitored continuously rather than discussed once a year at renewal, they are no longer simply describing volatility. They are showing how it is being managed. In my experience, insurers respond far more positively to evidence of governance, consistency and action than they do to retrospective explanations.
Why 90 Days Changes the Conversation
Continuous data is often misunderstood. It is not about overwhelming employers or underwriters with endless dashboards.
It is about tracking the handful of indicators that genuinely alter the risk story: absence frequency and duration, stress-related trends, musculoskeletal issues, return-to-work effectiveness and utilisation of support services. When those indicators are monitored consistently, brokers can separate temporary fluctuations from deeper structural problems.
The strongest renewal case emerges when workforce health information is connected directly to business outcomes. Deloitte has argued that wellbeing should be measured through outcomes rather than activity alone and has cited a return of £4.70 for every £1 invested in wellbeing in its mental health research.
However, finance leaders are rarely persuaded by generic wellbeing claims. What matters is whether the evidence explains what is happening inside their organisation. The objective is not to prove that wellbeing is universally profitable. The objective is to demonstrate how workforce health risks are influencing claims experience, productivity and retention within a specific employer context.
That distinction is important because it changes the quality of the renewal conversation. It moves the discussion away from abstract wellbeing programmes and towards measurable business risk.
The Value of Continuous Evidence
What I have found repeatedly is that continuous evidence changes the nature of decision-making across the organisation.
For HR leaders, renewal becomes an opportunity to demonstrate control over absence management, employee support and leadership response.
For Risk leaders, it provides evidence that workforce health is being managed as an operational risk rather than treated as a peripheral benefits issue.
For Finance teams, it creates a clearer connection between premium movements, claims experience and the interventions implemented during the year.
The practical implications are straightforward. If a broker arrives 90 days before renewal carrying little more than year-end claims data, the employer has limited ability to demonstrate progress. By contrast, organisations that have been monitoring trends, intervening early and documenting actions throughout the year can turn the renewal submission into a strategic asset.
That matters even more now that absence and mental health have become board-level concerns rather than issues discussed exclusively within HR functions.
What This Means for HR and Risk
The most effective renewal processes are not built on volume. They are built on discipline.
The organisations that achieve stronger outcomes tend to focus on a small set of consistent inputs that create continuity, comparability and business relevance.
- Maintain a rolling workforce health view that is updated monthly so the renewal narrative reflects the current risk position rather than a historical snapshot.
- Develop a clear account of what has changed, what actions have been taken and which issues remain unresolved. Underwriters typically price uncertainty more aggressively than they price known problems that are actively being managed.
- Demonstrate action against the primary drivers of stress and absence, aligned with organisational context and the HSE stress-risk framework.
- Quantify cost and productivity impact so that HR and Finance can engage in the same conversation rather than treating claims data as an isolated insurance matter.
- Begin the renewal process at least 90 days before renewal, creating enough time to challenge assumptions, address information gaps and prepare the account for market scrutiny.
The Commercial Payoff
The real value of continuous data is not administrative efficiency. It is leverage.
Even where claims performance is imperfect, brokers who can demonstrate trend analysis, intervention activity and management accountability are able to support a stronger renewal discussion. Insurers are not simply evaluating what happened in the past. They are assessing whether they have confidence in how risk will be managed going forward.
That is why the 90-day window matters.
It creates the opportunity to move from reaction to evidence, and from evidence to strategy. At a time when sickness absence remains elevated and work-related stress continues to account for a substantial proportion of lost working days, the organisations that secure better outcomes will be those that treat renewal as an ongoing risk-management discipline rather than a date on the calendar.
The renewal conversation has already started. The market is already forming a view.
The question for brokers, HR leaders and risk professionals is not whether they will be asked what changed this year. They will.
The real question is whether they will answer with a collection of reports—or with clear evidence that risk was understood, monitored and actively controlled.